Publication:
Juvenile Generalized Myasthenia Gravis: Presented as Unilateral Blepharoptosis and Successfully Managed with Pulse Intravenous Methylprednisolone

creativeworkseries.issn1812-2027
dc.contributor.authorPoudel, P
dc.contributor.authorAnand, A
dc.contributor.authorGhosh, S
dc.date.accessioned2025-12-18T08:01:25Z
dc.date.available2025-12-18T08:01:25Z
dc.date.issued2021
dc.descriptionPoudel P, Anand A, Ghosh S Department of Paediatrics and Adolescent Medicine B.P. Koirala Institute of Health Sciences, Dharan, Nepal
dc.description.abstractABSTRACT Myasthenia Gravis is a rare autoimmune disorder of childhood and this is rarer in South Asia. We present a pre-pubertal 7 year old female child of seropositive Generalized Juvenile Myasthenia Gravis. She presented with unilateral blepharoptosis and later generalized symptoms appeared. Ice-pack test, Neostigmine challenge test and acetylcholine receptor antibody test were positive. Serum muscle specific tyrosine kinase antibody test was normal. She did not have thymic abnormalities. She did not respond to high dose (26 mg/kg/day) of Pyridostigmine and oral Prednisolone (2 mg/kg/day), but was successfully treated with a combination of pulse intravenous Methylprednisolone (30 mg/kg once a month for 6 months) and daily doses of oral Prednisolone (2 mg/kg/day) along with Pyridostigmine without significant side effects. This combination can be considered a potential inexpensive treatment for Juvenile Myasthenia Gravis in a resource limited area where other immunosuppressive treatments such as intravenous immunoglobulin is expensive and unaffordable. KEY WORDS Blepharoptosis, Child, Methylprednisolone, Muscle weakness, Myasthenia gravis
dc.identifier.urihttps://hdl.handle.net/20.500.14572/3709
dc.language.isoen_US
dc.publisherKathmandu University
dc.subjectBlepharoptosis
dc.subjectChild
dc.subjectMethylprednisolone
dc.subjectMuscle weakness
dc.subjectMyasthenia gravis
dc.titleJuvenile Generalized Myasthenia Gravis: Presented as Unilateral Blepharoptosis and Successfully Managed with Pulse Intravenous Methylprednisolone
dc.typeArticle
dspace.entity.typePublication
local.article.typeCase Report
oaire.citation.endPage407
oaire.citation.startPage402
relation.isJournalIssueOfPublication007423ef-04ee-4725-9bdc-3d06afb050d7
relation.isJournalIssueOfPublication.latestForDiscovery007423ef-04ee-4725-9bdc-3d06afb050d7
relation.isJournalOfPublicationa782b7ff-cf89-4178-ad1c-11ed89cfe1bd

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
402-407.pdf
Size:
823.84 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections